Overtreatment of older men with prostate cancer raises concerns

Increasing percentages of some older U.S. men with intermediate-risk and high-risk prostate cancers are undergoing treatments that carry risks of side effects that can significantly reduce the quality of life without extending life, according to a new study led by Cedars-Sinai.

Covid biotech’s stock jumps after positive early PhIII monoclonal antibody data reveal

Invivyd on Monday reported positive early Phase III data for its monoclonal antibody designed to prevent symptomatic Covid-19 among immunocompromised individuals, triggering the biotech’s stock

December 19, 2023

CMS to increase reimbursement for new sickle cell gene therapies

The Centers for Medicare and Medicaid Services (CMS) said Wednesday that it will increase reimbursements for two newly approved sickle cell gene therapies that could

April 12, 2024

School cycling program linked to improved mental well-being in adolescents

Physical activity has positive effects on mental health and yet, activity rates are declining. This is particularly worrying because the mental well-being of teenagers continues

October 12, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.